Source: International Congress 2019 – Airway disease-associated exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Burrage (Brisbane, Australia), A. Halner (Oxford, United Kingdom), D. Nicolau (Brisbane, Australia), M. Bafadhel (Oxford, United Kingdom). Identifying tools to investigate outcomes following an exacerbation of COPD. 4300

Member's Comments

No comment yet.

Related content which might interest you: Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Predicting treatment outcomes following an exacerbation of airways disease Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Using characteristics of asthma phenotypes to determine exacerbation severity Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study Source: International Congress 2017 – Management of COPD Year: 2017 Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Defining acute asthma severity – how do worldwide asthma guidelines compare? Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018 Combining digital technologies to monitor asthma control and predict asthma exacerbations Source: Virtual Congress 2020 – Digital health: a brave new world? Year: 2020 Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Source: Eur Respir J 2014; 43: 662-664 Year: 2014 Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation? Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Important attributes of COPD exacerbations: a conjoint analysis Source: Eur Respir J 2004; 24: Suppl. 48, 514s Year: 2004 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019